Mirabegron induces relaxant effects via cAMP signaling‐dependent and ‐independent pathways in detrusor smooth muscle
- 10 January 2019
- journal article
- research article
- Published by Wiley in LUTS: Lower Urinary Tract Symptoms
- Vol. 11 (2) , O209-O217
Abstract
Objective We previously found that mirabegron exerts a relaxant effect in the presence of the β3‐adrenoceptor antagonist SR58894A during carbachol‐induced contraction in human and pig detrusor. The aim of this study was to explore the possible mechanism underlying the relaxant effects of mirabegron using detrusor smooth muscle. Methods Human tissue was obtained from urinary bladders of patients undergoing radical cystectomy at Kyushu University and Harasanshin Hospital. Pig tissue was obtained from an abattoir. Tension force (organ bath experiments) was measured in intact or permeabilised (α‐toxin or β‐escin) detrusor smooth muscle strips. The contribution of cAMP‐dependent signaling and the inhibition of Ca2+ sensitization to the relaxant effects of mirabegron were characterized using 1 μM SR58894A, 100 μM SQ22536 (an adenylyl cyclase inhibitor), 10 μM H‐89 (a protein kinase [PK] A inhibitor), 10 μM Y‐27632 (a selective Rho kinase inhibitor), and 10 μM GF‐109203X (a selective PKC inhibitor). Results 30 μM Mirabegron impaired carbachol (0.03‐1 μM)‐induced contraction in human detrusor smooth muscle. SR58894A only partially attenuated the relaxant effects of mirabegron in human and pig detrusor strips precontracted with 1 μM carbachol. In α‐toxin‐permeabilized detrusor strips, tension force at 1 μM [Ca2+]i was decreased by mirabegron in a concentration‐dependent manner. The relaxant effect of mirabegron was only slightly attenuated by H‐89 and not significantly affected by SQ22536. Y‐27632 potentiated the relaxation response to mirabegron, but attenuated responses to cAMP; GF‐109203X had little effect. Mirabegron but not cAMP had a notable relaxant effect in the pig detrusor smooth muscle permeabilized with β‐escin. Conclusions Mirabegron‐induced relaxation of pig and human detrusor smooth muscle occurs via both a β3‐adrenoceptor/cAMP‐dependent and ‐independent pathway.Keywords
This publication has 35 references indexed in Scilit:
- Expression ofβ‐Adrenoceptor Subtypes in Urothelium, Interstitial Cells and Detrusor of the Human Urinary BladderLUTS: Lower Urinary Tract Symptoms, 2013
- Persistence with prescribed antimuscarinic therapy for overactive bladder: a UK experienceBJU International, 2012
- β-Adrenoceptor agonist effects in experimental models of bladder dysfunctionPharmacology & Therapeutics, 2011
- Clinical guidelines for overactive bladderInternational Journal of Urology, 2009
- Epac and the cardiovascular systemCurrent Opinion in Pharmacology, 2007
- Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladderBritish Journal of Pharmacology, 2006
- The standardisation of terminology of lower urinary tract function: Report from the standardisation sub‐committee of the International Continence SocietyNeurourology and Urodynamics, 2002
- A Novel Phosphoprotein Inhibitor of Protein Type-1 Phosphatase HoloenzymesBiochemistry, 1999
- EXPRESSION OF beta 3-ADRENOCEPTORS IN RAT DETRUSOR SMOOTH MUSCLEJournal of Urology, 1998
- Characteristics of Ca2+- and Mg2+-induced tension development in chemically skinned smooth muscle fibers.Journal of General Physiology, 1978